Trial intelligence / Profile preview

Efficacy and Safety of Rotarix Vaccine in Healthy Chinese Infants

NCT01171963Phase 3Completed

Sponsor
GSK
Start
Aug 2010
Primary completion
May 2012
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus infection, sponsored by GSK. Started Aug 2010; status: completed.

02

Drugs

rotavirus vaccine, live, oral
03

Conditions

rotavirus infection

Beyond the preview

Go deeper on NCT01171963.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01171963.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call